2023 annual financial data
Telix Pharmaceuticals 2023 Net margin
Direct answer
Net margin was 1.04%.
Operating income was 15,840,000 AUD and net income was 5,211,000 AUD.
Operating cash flow was 23,884,000 AUD.
Get free Telix Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 502,547,000 AUD
- Operating income
- 15,840,000 AUD
- Net income
- 5,211,000 AUD
- Operating cash flow
- 23,884,000 AUD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Telix Pharmaceuticals financial years